Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1075)
CRISPR Therapeutics AG (CRSP)
Patel Naimish — Chief Medical Officer
Shares
3,786
Price
$55.62
Total Value
$210.58K
Shares Held After
19,357
% of Holdings
16.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$559.41
Total Value
$179.01K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
841
Price
$558.81
Total Value
$469.96K
Shares Held After
40,833
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
918
Price
$557.80
Total Value
$512.06K
Shares Held After
41,674
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
461
Price
$556.67
Total Value
$256.62K
Shares Held After
42,592
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$555.59
Total Value
$555.59K
Shares Held After
43,053
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
817
Price
$554.57
Total Value
$453.08K
Shares Held After
44,053
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
823
Price
$553.73
Total Value
$455.72K
Shares Held After
44,870
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$552.58
Total Value
$375.75K
Shares Held After
45,693
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
986
Price
$551.34
Total Value
$543.62K
Shares Held After
46,373
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,605
Price
$550.60
Total Value
$883.71K
Shares Held After
47,359
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
769
Price
$549.59
Total Value
$422.64K
Shares Held After
48,964
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$548.60
Total Value
$153.61K
Shares Held After
49,733
% of Holdings
0.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
6,000
Price
$19.87
Total Value
$119.22K
Shares Held After
67,845
% of Holdings
8.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
32,556
Price
$0.45
Total Value
$14.65K
Shares Held After
622,579
% of Holdings
5.0%
Alkermes plc. (ALKS)
Parisi Samuel Joseph — VP, Finance (Interim PAO)
Shares
16,217
Price
$42.36
Total Value
$687.01K
Shares Held After
7,717
% of Holdings
67.8%
PRECIGEN, INC. (PGEN)
Sabzevari Helen — President and CEO
Shares
119,250
Price
$4.36
Total Value
$519.93K
Shares Held After
3,768,872
% of Holdings
3.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
419
Price
$13.95
Total Value
$5.85K
Shares Held After
194,655
% of Holdings
0.2%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
2,441
Price
$13.95
Total Value
$34.05K
Shares Held After
939,634
% of Holdings
0.3%
PRECIGEN, INC. (PGEN)
Lehr Donald P. — Chief Legal Officer
Shares
29,131
Price
$4.36
Total Value
$127.01K
Shares Held After
755,461
% of Holdings
3.7%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
42,703
Price
$4.36
Total Value
$186.19K
Shares Held After
497,751
% of Holdings
7.9%
PRECIGEN, INC. (PGEN)
Tennant Phil — Chief Commercial Officer
Shares
30,272
Price
$4.36
Total Value
$131.99K
Shares Held After
139,369
% of Holdings
17.8%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
41,884
Price
$4.36
Total Value
$182.61K
Shares Held After
554,535
% of Holdings
7.0%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,669
Price
$109.30
Total Value
$182.42K
Shares Held After
59,634
% of Holdings
2.7%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
900
Price
$108.14
Total Value
$97.33K
Shares Held After
61,303
% of Holdings
1.4%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,530
Price
$107.45
Total Value
$164.40K
Shares Held After
62,203
% of Holdings
2.4%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,401
Price
$106.32
Total Value
$148.95K
Shares Held After
63,733
% of Holdings
2.2%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
100
Price
$109.76
Total Value
$10.98K
Shares Held After
58,117
% of Holdings
0.2%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,500
Price
$109.30
Total Value
$163.95K
Shares Held After
58,217
% of Holdings
2.5%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,178
Price
$108.01
Total Value
$127.24K
Shares Held After
59,717
% of Holdings
1.9%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,422
Price
$107.33
Total Value
$152.62K
Shares Held After
60,895
% of Holdings
2.3%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,300
Price
$106.26
Total Value
$138.14K
Shares Held After
62,317
% of Holdings
2.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
679
Price
$16.00
Total Value
$10.86K
Shares Held After
47,122
% of Holdings
1.4%
Jazz Pharmaceuticals plc (JAZZ)
Pearce Samantha — EVP, Chief Commercial Officer
Shares
6,907
Price
$235.41
Total Value
$1.63M
Shares Held After
50,272
% of Holdings
12.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
27,698
Price
$0.46
Total Value
$12.74K
Shares Held After
655,135
% of Holdings
4.1%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
30,208
Price
$2.98
Total Value
$90.02K
Shares Held After
62,586
% of Holdings
32.6%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
200
Price
$2.71
Total Value
$542.00
Shares Held After
62,586
% of Holdings
0.3%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
55,604
Price
$2.70
Total Value
$150.13K
Shares Held After
62,786
% of Holdings
47.0%
Equillium, Inc. (EQ)
Tom Penny — Principal Accounting Officer
Shares
65,000
Price
$2.95
Total Value
$191.75K
Shares Held After
0
% of Holdings
100.0%
Immunovant, Inc. (IMVT)
Fromkin Andrew J. — Director
Shares
210,468
Price
$33.56
Total Value
$7.06M
Shares Held After
74,382
% of Holdings
73.9%
Immunovant, Inc. (IMVT)
Fromkin Andrew J. — Director
Shares
11,483
Price
$32.64
Total Value
$374.81K
Shares Held After
284,850
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
300
Price
$571.55
Total Value
$171.46K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
260
Price
$570.76
Total Value
$148.40K
Shares Held After
40,813
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
227
Price
$569.57
Total Value
$129.29K
Shares Held After
41,073
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
728
Price
$568.78
Total Value
$414.07K
Shares Held After
41,300
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,339
Price
$567.76
Total Value
$760.23K
Shares Held After
42,028
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,261
Price
$566.72
Total Value
$714.63K
Shares Held After
43,367
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
563
Price
$565.69
Total Value
$318.49K
Shares Held After
44,628
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,369
Price
$564.59
Total Value
$772.92K
Shares Held After
45,191
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,638
Price
$563.68
Total Value
$923.31K
Shares Held After
46,560
% of Holdings
3.4%
Showing 1–50 of 1075 transactions (page 1 of 22)